New Threads Only:  Add to Google Reader or Homepage
New Threads & Replies:  Add to Google Reader or Homepage
Forums are for serious investors only. GuruFocus Forum Rules.

Forum List » Business News and Headlines
SEC Filings, Earing Reports, Press Releases
New Topic Search
Goto Thread: PreviousNext
Goto: Forum ListMessage ListNew TopicSearchLog In
Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker buys 11,800 Shares
Posted by: gurufocus (IP Logged)
Date: November 20, 2012 01:06PM

CEO of Progenics Pharmaceuticals, Inc. (PGNX) Mark Robert Baker buys 11,800 shares of PGNX on 11/19/2012 at an average price of $1.96 a share.

Progenics Pharmaceuticals, Inc. has a market cap of $63 million; its shares were traded at around $2.18 with and P/S ratio of 0.7.

CEO Recent Trades:


  • CEO Mark Robert Baker bought 11,800 shares of PGNX stock on 11/19/2012 at the average price of 1.96. Mark Robert Baker owns at least 155,265 shares after this. The price of the stock has increased by 11.22% since.
  • CEO Mark Robert Baker bought 49,793 shares of PGNX stock on 11/16/2012 at the average price of 1.82. Mark Robert Baker owns at least 143,465 shares after this. The price of the stock has increased by 19.78% since.
  • CEO Mark Robert Baker bought 48,833 shares of PGNX stock on 11/15/2012 at the average price of 1.69. Mark Robert Baker owns at least 93,672 shares after this. The price of the stock has increased by 28.99% since.
  • CEO Mark Robert Baker bought 1,162 shares of PGNX stock on 10/24/2012 at the average price of 2.96. Mark Robert Baker owns at least 44,839 shares after this. The price of the stock has decreased by 26.35% since.
  • CEO Mark Robert Baker bought 1,036 shares of PGNX stock on 09/26/2012 at the average price of 3.32. Mark Robert Baker owns at least 43,677 shares after this. The price of the stock has decreased by 34.34% since.

Directors and Officers Recent Trades:


  • Senior VP Medical Affairs Robert J Israel sold 1,000 shares of PGNX stock on 07/02/2012 at the average price of 9.79. Robert J Israel owns at least 35,050 shares after this. The price of the stock has decreased by 77.73% since.
  • Senior VP Medical Affairs Robert J Israel sold 1,000 shares of PGNX stock on 06/01/2012 at the average price of 8.51. Robert J Israel owns at least 38,383 shares after this. The price of the stock has decreased by 74.38% since.


For the complete insider trading history of PGNX, click here.


Stocks Discussed: PGNX,
Rate this post:




Sorry, only registered users may post in this forum.

Please Login if you have an account or Create a Free Account if you don't




Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial